Scorpius Holdings, Inc.

    Jurisdiction
    United States
    ISIN
    US42237K4094 (SCPX)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    1 / 9

    Profile

    NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €6.98T
    Gross margin
    35.3%
    EBIT
    -€44.32T
    EBIT margin
    -634.8%
    Net income
    -€53.73T
    Net margin
    -769.5%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Add to watchlist

    Notifications